Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cellebrite DI Q2 2024 Adj. EPS $0.10 Beats $0.05 Estimate, Sales $95.714M Beat $91.963M Estimate

Author: Benzinga Newsdesk | August 15, 2024 07:08am
Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.05 by 100 percent. This is a 100 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $95.714 million which beat the analyst consensus estimate of $91.963 million by 4.08 percent. This is a 24.82 percent increase over sales of $76.684 million the same period last year.

Posted In: CLBT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist